Shareholding disclosure

senior management and board of directors

Declared position

3.64%

Threshold

Crossed upwards

Timeline

Published

14.10.2016

Transaction

12.10.2016

Voting rights breakdown

Voting rights acquired3.64%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TBGAC00022

Beneficial owner

senior management and board of directors

Declared address

senior management and board of directors

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

senior management and board of directors

Newron Pharmaceuticals S.p.A.14.10.2016TBGAC00022

Disclosure summary

senior management and board of directors disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 14.10.2016, at 3.64% of voting rights. Notice category: Group of shareholders.

Disclosed position

3.64%

Voting rights acquired

Voting rights acquired3.64%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

senior management and board of directors disclosed a holding in Newron Pharmaceuticals S.p.A., published on 14.10.2016.

Publication date14.10.2016

Transaction date12.10.2016

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownersenior management and board of directors

Declared addresssenior management and board of directors

CategoryGroup of shareholders

Voting rights acquired3.64%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTBGAC00022

Source: SIX Exchange Regulation · Publication date: 14.10.2016

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open